Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.
As of 17 September 2014, its market capitalisation was â‚¹517 billion (US$8.1 billion)(US$7.7 billion), making it India's 42nd largest publicly traded company by market value.
